Trial intelligence / Profile preview

Lippia alba ethanolic extract in migraine

NCT01259947Phase 2Completed

Start
Jul 2006
Primary completion
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Lippia alba ethanolic extract in migraine. Started Jul 2006; status: completed.

02

Drugs

Lippia alba ethanolic extract
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01259947.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01259947.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call